Neurobiologically-based treatments in Rett syndrome: opportunities and challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neurobiologically-based treatments in Rett syndrome: opportunities and challenges

Published:2016-09-10 Issue:10 Volume:4 Page:1043-1055
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Kaufmann Walter E.,Stallworth Jennifer L.,Everman David B.,Skinner Steven A.

Funder

National Institutes of Health

Rettsyndrome.org

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://tandfonline.com/doi/pdf/10.1080/21678707.2016.1229181

Reference130 articles.

1. Pathways to Drug Development for Autism Spectrum Disorders

2. Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes

3. Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back

4. Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

5. Rett syndrome: Revised diagnostic criteria and nomenclature

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rett syndrome: The Natural History Study journey;Annals of the Child Neurology Society;2024-08-11

2. Is trofinetide a future treatment for Rett syndrome? A comprehensive systematic review and meta-analysis of randomized controlled trials;BMC Medicine;2024-07-18

3. Trofinetide providing a promising avenue for the treatment of Rett syndrome;International Journal of Scientific Reports;2024-03-28

4. Safety and efficacy of trofinetide in Rett syndrome: a systematic review and meta-analysis of randomized controlled trials;BMC Pediatrics;2024-03-23

5. Zebrafish in understanding molecular pathophysiology, disease modeling, and developing effective treatments for Rett syndrome;The Journal of Gene Medicine;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3